The phrase "a robust screening" is correct and usable in written English.
It can be used when referring to a thorough and effective process of evaluating or assessing something, such as candidates, data, or products.
Example: "The company implemented a robust screening process to ensure that only the most qualified candidates were selected for the position."
Alternatives: "a thorough evaluation" or "a comprehensive assessment."
Appearing before the House Judiciary Committee, Attorney Lynch said that the US has a "robust" screening process that's stronger than any place in Europe.
The bulk of the time is spent trying to solve particular problems such as design of a robust screening assay or finding the best way of testing the effectiveness of a compound in vivo.
DoE ICA DS allowed encountering optimal operating conditions to obtain a robust screening method for the 19 considered antimalarial drugs in the framework of the fight against counterfeit medicines.
This is because the United States has developed a robust screening and background check that assures us that we know who we are welcoming into this country.
One of the hurdles in large-scale gene knockdown experiments is the development of a robust screening system to identify shRNAs with the intended effect.
The need for a robust screening system becomes increasingly important as the size of the shRNA library increases, since the majority of shRNAs in a given shRNA library pool will most likely not provide the desired phenotype.
A robust screen must identify compounds that specifically target the events within the autophagic or endolysosomal pathway, as they share many common cellular regulatory mechanisms [ 12].
Second, measurement of the Z′ value, a widely used HTS assay metric for determining the separation between negative and positive controls where Z′ > 0.5 indicates a robust screen, yielded a favorable value, Z′ = 0.76.
This model has been validated previously as a robust screen for therapeutic efficacy since anti-TNFα [ 4] and anti-soluble IL-6 receptor [ 5] antibodies suppress inflammation in similar models.
Our use of highly purified flow sorted tumor populations and the ability to detect homozygous deletions and mutations in PDA clinical samples, regardless of cellularity and tumor content, provides a robust screen for potential tumor suppressors.
Moreover, a wide range of disorders were examined by a psychometrically robust screening tool, and some pre-disaster factors were taken into account beyond trauma exposure.
